These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2281031)

  • 1. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers.
    Chan KK; Mojaverian P; Ziehmer BA; John VA
    Pharm Res; 1990 Oct; 7(10):1026-32. PubMed ID: 2281031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteers.
    Alioth C; Blum RA; D'Andrea DT; Kochak GM; Teng L; Ziehmer BA; Schentag JJ; Chan KK
    Pharm Res; 1993 Nov; 10(11):1688-92. PubMed ID: 8290486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
    Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
    J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
    Paton DM
    Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.
    Macía MA; Frias J; Carcas AJ; Guerra P; Valiente R; Lucero ML
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):333-9. PubMed ID: 7582384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
    Kambayashi A; Blume H; Dressman JB
    Eur J Pharm Biopharm; 2014 Jul; 87(2):236-43. PubMed ID: 24462791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
    Hasan MM; Najib NM; Muti H
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools.
    Van Den Abeele J; Schilderink R; Schneider F; Mols R; Minekus M; Weitschies W; Brouwers J; Tack J; Augustijns P
    Mol Pharm; 2017 Dec; 14(12):4220-4232. PubMed ID: 28621952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations.
    Su SF; Chou CH; Kung CF; Huang JD
    Int J Pharm; 2003 Jul; 260(1):39-46. PubMed ID: 12818808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the population pharmacokinetic parameters of sustained-release and enteric-coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting using NONMEM.
    Idkaidek NM; Amidon GL; Smith DE; Najib NM; Hassan MM
    Biopharm Drug Dispos; 1998 Apr; 19(3):169-74. PubMed ID: 9570000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.